Cefpodoxime Proxetil Floating Microspheres: Formulation and In VitroEvaluation Formulation cefpodoxime proxetil floating microspheres
Iranian Journal of Pharmaceutical Sciences,
Vol. 5 No. 2 (2009),
1 Farvardin 2009
,
Page 69-72
https://doi.org/10.22037/ijps.v5.41188
Abstract
The objective of the present study was to develop floating microspheres of cefpodoxime proxetil in order to achieve an extended retention in the upper GIT,which may result in enhanced absorption and the reby improved bioavailability. The microspheres were prepared by non-aqueous solvent evaporation method using polymers such as hydroxyl propyl methyl cellulose (HPMC K 15 M), ethyl cellulose in different ratios and cefpodoxime proxetil in each formulation.In vitro drug release were performed by USPapparatus type I and the microspheres were characterized by polymer compatibility by using FT-IR. The yield, particle size,Buoyancy percentage, drug entrapment efficiency, andin vitrodrug release werestudied. The result showed that microspheres yielded 50.5-72.2%. The particlesize was distributed between75-600 μm, drug entrapment efficiency was 14.1-28.2%, and Buoyancy percentage was 70.1-88.3%. The best drug release profiles were seen with formulation 2 at the ratio of drug to polymer of 1:2.
- Cefpodoxime proxetil
- Floating microspheres
- In vitrorelease studies
How to Cite
References
[2]Dave BS, Amin AF, Patel MM. Gastroretensive drug delivery of ranitidine hydrochloride:Formulatin and in vitro evaluation. AAPS Pharm Sci Tech2004; 5: Article 34.
[3]Kakumanu VK, Arora VK, Bansal AK.Investigation of factors responsible for low oral bioavailability of cefpodoxime proxetil. Int J Pharmaceutics2006; 317: 155-60.
[4]Crauste-Manciet S, Brossard D, Decroix MO,Farinotti R, Chaumeil JC. Cefpodoxime-proxetil protection from intestinal lumen hydrolysis by oil-in-water submicron emulsions. Int J Pharmaceutics1998; 165: 97-106.
[5]Merchant HA, Shoib HM, Tween T, Rabia I.Once daily tablet formulatin and in vitro release evaluation of cefpodoxime using HPMC: Atechnical note.AAPS Pharm Sci Tech2006; 7:Article 78.
[6]Geogiannis VS, Rekkas DM, Dallas PP, Choulis NH. Floating and swelling characteristics of various exipients used in controlled release technololgy. Drug Dev Ind Pharm1993; 19:1061-81.
[7]Kumar Srivastava A, Ridhurkar DN. Floating microspheres of cimetidine: Formulation charac-terization and in vitroevaluation. Acta Pharm2005; 55: 277-85.
[8]Patel A, Ray S, Thakur RS.In vitro evaluation and optimization of controlled release floating drug delivery system of metformin hydrochloride.Daru2006; 14: 57-64.
- Abstract Viewed: 311 times
- IJPS_Volume 5_Issue 2_Pages 69-72 Downloaded: 267 times